Skip to main content

Advertisement

Figure 1 | Annals of General Psychiatry

Figure 1

From: Atomoxetine treatment for nicotine withdrawal: a pilot double-blind, placebo-controlled, fixed-dose study in adult smokers

Figure 1

Mean scores on the Cigarette Dependence Scale (CDS). The figure shows the changes in the mean scores on the CDS over the 3-week study period in the group receiving placebo (placebo group), those receiving atomoxetine who completed the study (atomoxetine group), and those who received atomoxetine but dropped out during the study (last observation carried forward (LOCF) atomoxetine group). A two-sample t test demonstrated statistically significant difference (P < 0.05) between the mean scores in the atomoxetine group compared to the placebo groups at 3 weeks (*).

Back to article page